Tag Archives: rVSV-ZEBOV-GP

Kampala, Uganda | THE INDEPENDENT | A second experimental Ebola vaccine, manufactured by Johnson & Johnson is due to be introduced in the Democratic Republic of Congo. This vaccine, which is given as a 2-dose course, 56 days apart, will be provided under approved protocols to targeted at-risk populations in …

Read More »